However, again, this is something you should discuss with your provider
Open the calculator as a procurement planning aid for vial mass, diluent-volume records, and target concentration notes
Medicare Part D has a statutory exclusion for weight loss medications, so Zepbound, Wegovy, and Saxenda are not covered when prescribed for weight loss
However, as higher CRLB are expected for lower concentration metabolites, using a strict CRLB cutoff for low-concentration metabolites like Gln and GABA can introduce a systematic bias toward higher concentrations as lower concentrations are more likely to be excluded
Oxid Med Cell Longev 6(2022):113 Zsurka G, Kunz WS (2010) Mitochondrial dysfunction in neurological disorders with epileptic phenotypes